Download PDF

Other users also viewed these articles

Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study Samantha Thifani Alrutz Barcelos; Amanda Souza Silva-Sperb; Helena Abadie Moraes; Larisse Longo; Bruna Concheski de Moura; Matheus Truccolo Michalczuk; Carolina Uribe-Cruz; Carlos Thadeu Schmidt Cerski; Themis Reverbel da Silveira; Valesca Dall'Alba; Mário Reis Álvares-da-Silva;
Ann Hepatol. 2023;28:
METABOLIC ASSOCIATED STEATOTIC LIVER DISEASE-RELATED SIGNIFICANT AND ADVANCED FIBROSIS' PREVALENCE IN BRAZIL AND THE ASSOCIATED ACCURACY OF FIB-4 AND VIBRATION-CONTROLLED ELASTOGRAPHY - A NATIONAL REGISTER Cristiane Alves Villela-Nogueira; Cristiane Valle Tovo; Nathalie Carvalho Leite; Mário Reis Álvares-da-Silva; Claudia Alexandra Ivantes; Claudia Alves Couto; Giovanni Faria Silva; Edson Roberto Parise; Ana Carolina Cardoso; Natalia Ballassiano Wajsbrot; Luis Fernando Ferreira; Muriel Manica; Gabriela Perdomo Coral; Matheus Michalczuk; Rafael Biesek Novaes; Brian Vinícius Batista Pinheiro; Rosangela Réa; Luciana Costa Faria; Fernando Gomes Romeiro; Leila Priscilla Pinheiro da Silva; Roberto Carvalho Filho; Marcelo Chagas; Mariana Sharp; Luiza Soares Dantas; José Tadeu Stefano; Isabel Veloso Pereira; Patricia Momoyo Zitelli; Mário Guimarães Pessoa; Carlos Terra; Claudia P.M.S. Oliveira;
Ann Hepatol. 2025;30 Supl 2:
Clinically significant portal hypertension in patients with primary biliary cholangitis: Clinicopathological features and prognostic value Ying Zhang; Huaying Lai; Jing Chen; Ruimin Lai; Xiaoyu Lin; Shan Lin; Bingping Liu; Qiuxiang Lin; Bin Wang; Qi Zheng;
10.1016/j.aohep.2024.101577